Cargando…
Abnormal immunothrombosis and lupus anticoagulant in a catastrophic COVID-19 recalling Asherson’s syndrome
BACKGROUND: Coronavirus disease 2019 (COVID-19) is a complex disease with many clinicopathological aspects, including abnormal immunothrombosis, and the full comprehension of its pathogenetic mechanisms is urgently required. METHODS/RESULTS: By means of a multidisciplinary approach, we here report a...
Autores principales: | Roncati, Luca, Corsi, Lorenzo, Barbolini, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040358/ https://www.ncbi.nlm.nih.gov/pubmed/33844151 http://dx.doi.org/10.1007/s11239-021-02444-0 |
Ejemplares similares
-
The COVID-19 Arterial Thromboembolic Complications: From Inflammation to Immunothrombosis Through Antiphospholipid Autoantibodies
por: Roncati, Luca, et al.
Publicado: (2021) -
ANTICOAGULATION, BLEEDING, AND IMMUNOTHROMBOSIS IN CRITICALLY ILL PATIENTS WITH COVID-19
por: PAEZ VARGAS, JUAN, et al.
Publicado: (2021) -
Case Report: An Unusual Case of Acute Lower Limb Ischemia as Precursor of the Asherson's Syndrome
por: Pasqui, Edoardo, et al.
Publicado: (2021) -
Immunothrombosis in severe COVID-19
por: Nakazawa, Daigo, et al.
Publicado: (2020) -
COVID-19: Lung-Centric Immunothrombosis
por: Kvietys, Peter R., et al.
Publicado: (2021)